1. Home
  2. INSG vs RNXT Comparison

INSG vs RNXT Comparison

Compare INSG & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inseego Corp.

INSG

Inseego Corp.

HOLD

Current Price

$3.01

Market Cap

74.5M

ML Signal

HOLD

Logo RenovoRx Inc.

RNXT

RenovoRx Inc.

HOLD

Current Price

$0.95

Market Cap

79.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INSG
RNXT
Founded
1996
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
74.5M
79.4M
IPO Year
2000
2021

Fundamental Metrics

Financial Performance
Metric
INSG
RNXT
Price
$3.01
$0.95
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
4
Target Price
★ $9.17
$7.25
AVG Volume (30 Days)
230.9K
★ 455.1K
Earning Date
11-04-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 20.00
EPS
N/A
★ N/A
Revenue
★ $313,832,000.00
$1,123,000.00
Revenue This Year
N/A
$243.48
Revenue Next Year
$10.21
$196.42
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 2511.63
52 Week Low
$3.30
$0.77
52 Week High
$21.90
$2.59

Technical Indicators

Market Signals
Indicator
INSG
RNXT
Relative Strength Index (RSI) 32.52 35.92
Support Level N/A $0.83
Resistance Level $4.68 $1.02
Average True Range (ATR) 0.40 0.17
MACD -0.14 -0.01
Stochastic Oscillator 0.49 10.46

Price Performance

Historical Comparison
INSG
RNXT

About INSG Inseego Corp.

Inseego Corp is involved in the design and development of fixed and mobile wireless solutions (4G and 5G NR), Industrial Internet of Things, and cloud solutions for enterprises, service providers, small and medium-sized businesses, governments, and consumers around the globe. Its products and services include intelligent mobile hotspots, wireless routers for IoT applications, USB modems, integrated telematics and mobile tracking devices, which are supported by application software and cloud services designed to enable customers to analyze data insights and configure and manage their hardware easily. It generates maximum revenue from the United States and Canada. The company also has a presence in Europe (including the United Kingdom).

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical needs with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed for targeted therapeutic delivery across the arterial wall near the tumor site (known as intra-arterial, or IA delivery) to bathe the target tumor, while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

Share on Social Networks: